Head-to-head · Cost-Efficiency Index
Ro vs No BS RX
Two GLP-1 programs on the bench, scored on the same six factors. Here's how their real cost of ownership compares — and which one we'd start with.
Ro
People who need brand-name (Wegovy/Zepbound) access or insurance navigation and will accept price opacity for it.
Visit RoNo BS RX
Someone who wants every term and every dose level comparable without starting an intake to see a price.
Visit No BS RXThe verdict
Ro takes it, leading the Cost-Efficiency Index 84 to 82. The widest formulary — brand-name and oral access, with a named CMO — but the $149/mo (or $74/mo prepaid annual) membership fee is separate from the drug's own opaque, insurance-dependent price. No BS RX still earns a B− — Someone who wants every term and every dose level comparable without starting an intake to see a price.
Worth knowing either way: our overall #1 pick is CoreAge Rx (Cost-Efficiency Index 94/100 — the top of the ranking). See how it stacks up: CoreAge Rx vs Ro.
Factor by factor
Both providers scored on our six Cost-Efficiency Index factors. The stronger side on each row is marked in teal.
Normalized Cost/Month
Price Transparency
Nationwide Access
Formulation Options
Clinical Oversight
Contract Flexibility
Pricing, coverage & formulary
The disclosed facts behind the scores. Lower price wins its row (teal).
| Spec | Ro | No BS RX |
|---|---|---|
| Cost-Efficiency Index | 84/100 | 82/100 |
| Semaglutide / mo | Not disclosed (drug); $149/mo Ro Body membership separately | $179/mo month-to-month; a separate low-dose program runs $140 |
| Tirzepatide / mo | Not disclosed (drug); $149/mo Ro Body membership separately | $249/mo month-to-month; a separate low-dose program runs $140 |
| Semaglutide / yr (modeled) | — | $2,148 |
| Tirzepatide / yr (modeled) | — | $2,988 |
| Coverage | Multi-state | Not disclosed |
| Oral / sublingual | Yes | Yes |
| Brand-name access | Yes | Compounded only |
| Rank here | #22 | #28 |
Ro
84/100Where the value is
- Brand-name access and a dedicated insurance concierge to help navigate drug coverage
- Oral options (including the newer Foundayo/orforglipron pill) widen the formulary
- Named, credentialed Chief Medical Officer (Dr. Melynda Barnes, MD) and a public LegitScript certificate (#3722005)
The tradeoffs
- Does not publish compounded pricing up front — a blind spot in any cost model
- The $74/mo membership figure often quoted requires a full year prepaid upfront; month-to-month membership billing is $149/mo, and the drug cost is a separate charge on top of either
No BS RX
82/100Where the value is
- Names four dispensing pharmacies with street addresses and telephone numbers — Red Rock Compounding Pharmacy, Health Warehouse, Precision Medicine and Triad Rx
- "No Fake Intro Rate — the price on the page is the ongoing program price" is a named commitment, and the $140 in its hero really is a month-to-month rate
- Every program row prints "503A pharmacy fulfillment" and "No dose-based price changes" on the table itself
The tradeoffs
- The same $409 twelve-week block appears under three different monthly rates — an $11 saving against one and a $128 saving against another, styled identically
- The low-dose programs stop at twelve weeks; only the standard programs carry 24- and 52-week rungs
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. Pricing, states and verification reflect each provider's public disclosures at last review; prices change — confirm on the provider's site. Not medical advice. See our disclosure.